IRTG 2251 - ICSMD Seminar

The transCampus International Research Training Group (IRTG) 2251 “Immunological and Cellular Strategies in Metabolic Disease” (ICSMD) invites to the upcoming ICSMD Seminar


Invited Speaker: Dr John F. O’Sullivan, MD, PhD, FAHA, FRCPI 
                          Cardiometabolic Disease Group Leader, Heart Research Institute, Sydney |
                          Cardiologist, Royal Prince Alfred Hospital, Sydney

Title: Probing Cardiometabolic Disease

Date: Monday, 11th of December 2017

Time: 4.00 pm

Location : Conference Room H19, 1.158/9 University Hospital Carl Gustav Carus

 About the Speaker:

John O’Sullivan joined the HRI in 2016 as Cardiometabolic Disease Group Leader from Harvard Medical School and Massachusetts General Hospital where he was a Postdoctoral Fellow and Clinical Observer. John’s research focusses on the cardiovascular effects of obesity-driven metabolic diseases, which together are the greatest health challenges in the modern era. Combining genomic and metabolomic profiling in carefully-phenotyped patient cohorts, he has discovered several novel markers, effectors, and predictors of disease. Using animal and cellular models of disease, he has revealed the functional roles of these metabolites. 

For more information, please visit